Brosius Mark sold $30K of ISRG
Brosius Mark (EVP & Chief Mfg and Supply Cha) sold 84 shares of INTUITIVE SURGICAL INC (ISRG) at an average of $356.60 ($344.00–$365.58) across 3 trades over 2026-07-27 to 2026-07-29 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The newest fact is the specific open-market sale by an officer under a pre-arranged 10b5-1 plan; it does not provide new operational or financial information about ISRG.
Market read
Traders may note incremental insider selling, but the planned nature and modest dollar value suggest limited decision impact.
What to watch
The sale size is small relative to typical ISRG trading activity, and the disclosure does not include any new company-specific developments.
Background
The article is an SEC Form 4 insider transaction disclosure for Intuitive Surgical (ISRG).
Ticker impact
Form 4 shows ISRG EVP Mark Brosius sold $29,954 of shares in open-market trades under a pre-arranged 10b5-1 plan (84 shares).
Likely minimal near-term impact; any effect is typically absorbed as routine 10b5-1 selling.
The filing is an insider open-market sale, explicitly tied to a pre-arranged 10b5-1 plan, with no accompanying company-specific news (earnings, guidance, deal, or regulatory action).
Market effects
No direct read-through to medical device sector fundamentals from a small, planned insider sale.
None indicated.
None indicated.
Counterpoint
Even planned 10b5-1 sales can coincide with internal views on valuation or liquidity needs, so some traders may still treat it as mild bearish sentiment.
Key entities
- issuerISRG
Intuitive Surgical, the company whose insider transaction is disclosed.
- insiderBrosius Mark
EVP and Chief Mfg and Supply Chain officer who sold shares.
- trading mechanism10b5-1 plan
Pre-arranged plan indicating the trades were scheduled in advance.
